CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NovaTests is developing predictive tests for cancer treatment that assess a patient's sensitivity to radiation therapy through a simple blood sample. This innovation aims to personalize treatment plans, improving outcomes for cancer patients and enhancing their quality of life during and after therapy.
Each year, two out of three cancer patients undergo radiation therapy, meaning close to 1.5M patients in Europe and 2M in the US.
However, scientific evidences prove a direct link between radiation therapy and several serious late effects.
This because patient’s tolerance to radiation vary significantly and radiotherapy affects indiscriminately both healthy and cancer cells, damaging also active working cells, tissues or organs around the tumour.
There is, therefore, an unmet clinical need to ta…
NOVAGRAY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
